CLINICAL_TRIALS
trial_result
· 2012-04-20
Clinical Trial Update: Trial of RAD001 in Triple Negative Metastatic Breast Cancer [Phase 2]
Summary
A Phase 2 trial of RAD001 (everolimus) in triple-negative metastatic breast cancer was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-04-20